بدائل البحث:
significantly small » significantly smaller (توسيع البحث), significantly impact (توسيع البحث), significantly impair (توسيع البحث)
alter decrease » larger decrease (توسيع البحث), water decreases (توسيع البحث), alter disease (توسيع البحث)
small decrease » small increased (توسيع البحث)
teer decrease » mean decrease (توسيع البحث), greater decrease (توسيع البحث)
significantly small » significantly smaller (توسيع البحث), significantly impact (توسيع البحث), significantly impair (توسيع البحث)
alter decrease » larger decrease (توسيع البحث), water decreases (توسيع البحث), alter disease (توسيع البحث)
small decrease » small increased (توسيع البحث)
teer decrease » mean decrease (توسيع البحث), greater decrease (توسيع البحث)
-
101
Table 3_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel...
منشور في 2024"…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …"
-
102
Statins resulted in smaller neuronal soma size.
منشور في 2025"…Areas of all BrdU + /Hu+ neurons measured in control birds (dark orange line) and statin-treated birds (light orange line) shows qualitatively that statins did not decrease soma sizes of small cells (overlap of orange lines), and statins did not curtail the upper limit of soma size (light orange line reaches a soma size of > 200 µm, Y axis, top panel). …"
-
103
-
104
-
105
-
106
Data Sheet 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and...
منشور في 2024"…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …"
-
107
-
108
-
109
-
110
-
111
-
112
Genetic alterations of CD70 in DLBCL.
منشور في 2024"…Compared with DLBCL patients with CD70 mutation, methylation levels of PKHD1, MAS1, and FIP1L1 were obviously increased, whereas RPL10A, MARCH10, FAM45A, and FAM45B were significantly decreased in DLBCL patients with CD70 mutation. …"
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120